World Summit on Neurology, Mental Health & Alzheimer's

The Times Scientific Group is organizing The World Summit on Neurology, Mental Health & Alzheimer's on April 06-07, 2026, in Amsterdam ,The Netherlands. This global event focuses on understanding, treating, and researching disorders related to the brain and nervous system. It brings together doctors, researchers, and healthcare professionals from around the world to share ideas, research findings, and new treatment methods.

Key areas of focus include neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, alongside the complexities of Stroke and Heart-Brain Neurological Disorders. Cutting-edge research in Neuro Immunology and Neurological Infections will also be highlighted, offering new insights into immune-mediated neurological conditions.

Specialized Sessions on Neuro-Oncology and Paediatric Neurology will address the unique challenges of treating neurological cancers and childhood neurological disorders. The conference will further explore the fields of Neuro-Ophthalmology & ENT, emphasizing sensory and cranial nerve pathologies, and Neuroplasticity and Neurorehabilitation, focusing on the brain’s remarkable ability to recover and adapt.

Critical neurological conditions such as Epilepsy and Seizure Disorders will be examined alongside innovative Clinical Interventions and Case Reports, providing practical knowledge to enhance patient outcomes. The transformative impact of Artificial Intelligence in Neurology will be showcased, highlighting its role in diagnostics, personalized medicine, and treatment planning.

The event will also address emerging concerns such as Post-Viral Neuromuscular Syndromes and Long COVID, and advances in Neurotechnology, facilitating new therapeutic modalities. Discussions on Dementia and Vascular Dementia and Neuropathic Pain Management will provide insights into managing complex neurodegenerative and pain syndromes. In the realm of mental health, the conference will focus on AI in Mental Health Care, leveraging technology to improve diagnosis and treatment. Dedicated sessions on Women’s Mental Health and Midwifery will address gender-specific challenges, while Public Mental Health initiatives will highlight strategies for community well-being. Key psychiatric conditions such as Stress, Anxiety, and Depression will be explored alongside Case Reports and Management of Mental Health, offering real-world clinical perspectives.

Finally, the conference will include a focus on Geriatric Psychiatry, emphasizing mental health care tailored to the aging population, ensuring comprehensive coverage of neurological and psychiatric disorders across all life stages. This multidisciplinary conference promises to foster collaboration, inspire innovation, and accelerate the translation of research into clinical practice, ultimately advancing the global standard of care in neurology and mental health.

Why to Attend Our World Summit on Neurology, Mental Health & Alzheimer's Conference?

This conference is a must-attend event for clinicians, researchers, mental health professionals, policymakers, and students who are passionate about advancing neurological and mental health care worldwide. Here’s what makes this event truly exceptional:

• Cutting-Edge Research and Innovation: Hear directly from world-renowned experts presenting the latest findings, clinical trials, and innovative therapies that are revolutionizing neurology and mental health treatment.
• Comprehensive Learning Opportunities: Attend keynote speeches, panel discussions, workshops, and poster sessions covering a wide range of topics including neurodegenerative diseases, psychiatric disorders, brain imaging, neuropharmacology, and emerging digital health technologies.
• Networking and Collaboration: Engage with a global community of professionals from diverse backgrounds. Build relationships that foster collaboration, interdisciplinary projects, and knowledge sharing beyond the conference.
• Professional Development: Earn continuing education credits, gain new skills, and enhance your professional credentials by participating in specialized sessions and certification programs.
• Patient-Centered Focus: Discover approaches that prioritize patient outcomes, mental wellness, and holistic care models, empowering you to make a meaningful impact in your practice or research.
• Platform for Young Researchers: The conference provides an invaluable stage for early-career scientists and clinicians to showcase their work, receive feedback, and connect with mentors and potential collaborators.

Why The Netherlands?

Choosing The Netherlands as the host country for our Neurology and Mental Health Conference is intentional and strategic for several compelling reasons

• A Global Leader in Health Innovation: The Netherlands boasts some of the world’s top neuroscience and mental health research institutions, fostering a culture of innovation and excellence in healthcare.
• Strategic Geographic Location: Situated in the heart of Europe, the Netherlands offers easy accessibility via major international airports like Amsterdam Schiphol, making it convenient for attendees from all continents.
• Multicultural and Welcoming Atmosphere: The country’s open and inclusive society makes it a comfortable and inspiring destination for international visitors, promoting cultural exchange and global dialogue.
• Excellent Conference Infrastructure: The Netherlands is known for its modern conference centres, world-class hotels, and efficient public transportation, ensuring a smooth and enjoyable experience for all participants.
• Rich Cultural and Historical Experience: Beyond the conference sessions, attendees can explore the Netherlands’ vibrant cities, iconic canals, world-famous museums, and diverse culinary scene — making the visit both intellectually and personally enriching.
• Commitment to Sustainability: The Netherlands leads in sustainable event management, reflecting the growing importance of environmental responsibility in global gatherings.

By hosting the conference in the Netherlands, we aim to create a dynamic, accessible, and inspiring platform where science, practice, and culture converge to advance the fields of World Summit on Neurology, Mental Health & Alzheimer's.

Visa & Travel Assistance:

All registered international participants will receive an official invitation letter to with their visa application. We recommend submitting applications early to ensure timely processing and smooth travel. Register early for the conference to secure your spot and enjoy all sessions, networking opportunities, and conference benefits without any hassle.

Neurology market analysis in the US,Europe & Asia for 2024-2025:

United States / North America

In 2024, the neurology drugs market in North America was valued at approximately USD 34.2 billion, representing about 51% of the global market share. Growth continues steadily into 2025, with the U.S. market estimated to reach around USD 32.9 billion, according to Cognitive Market Research. The region remains the largest globally, driven by strong R&D investment, rapid adoption of Alzheimer’s and migraine drugs, and favorable reimbursement systems. However, pricing pressures and patent expirations slightly limit year-on-year growth.

Europe

The European neurology drugs market was valued at about USD 28.7 billion in 2024, holding roughly 25–28% of global share. Growth into 2025 is moderate, projected at around 4–6%, as Europe remains a mature but stable market. The region’s expansion is supported by an ageing population and new biologic therapies, but strict pricing and reimbursement regulations continue to restrain faster adoption of high-cost innovations.

Asia / Asia–Pacific

In 2024, the Asia–Pacific neurology drugs market was valued at approximately USD 18.9 billion, accounting for 20–23% of the global total. It is expected to show the fastest growth among all regions, potentially reaching around USD 27 billion in 2025. This strong increase is fueled by rising healthcare spending, larger elderly populations, and greater access to diagnosis and treatment in key countries like China, Japan, and India. Despite rapid growth, challenges remain in affordability, infrastructure, and uneven regulatory systems.